225 related articles for article (PubMed ID: 29106960)
21. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
[TBL] [Abstract][Full Text] [Related]
22. Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGFβ/Smad and MAPK-JNK Signaling Pathways.
Park JH; Park B; Park KK
Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28406452
[TBL] [Abstract][Full Text] [Related]
23. Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
An SY; Jang YJ; Lim HJ; Han J; Lee J; Lee G; Park JY; Park SY; Kim JH; Do BR; Han C; Park HK; Kim OH; Song MJ; Kim SJ; Kim JH
Gastroenterology; 2017 Apr; 152(5):1174-1186. PubMed ID: 27956229
[TBL] [Abstract][Full Text] [Related]
24. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways.
Zhao HW; Zhang ZF; Chai X; Li GQ; Cui HR; Wang HB; Meng YK; Liu HM; Wang JB; Li RS; Bai ZF; Xiao XH
Int Immunopharmacol; 2016 Jul; 36():249-255. PubMed ID: 27179304
[TBL] [Abstract][Full Text] [Related]
25. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
26. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
[TBL] [Abstract][Full Text] [Related]
27. Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs.
Peng J; Li X; Feng Q; Chen L; Xu L; Hu Y
Exp Biol Med (Maywood); 2013 Jun; 238(6):668-77. PubMed ID: 23918878
[TBL] [Abstract][Full Text] [Related]
28. FAT10 Silencing Prevents Liver Fibrosis through Regulating SIRT1 Expression in Hepatic Stellate Cells.
Zheng W; Guan F; Xu G; Yu Y; Xiao J; Huang X
Int J Med Sci; 2023; 20(4):557-565. PubMed ID: 37057207
[No Abstract] [Full Text] [Related]
29. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.
Sui M; Jiang X; Chen J; Yang H; Zhu Y
Biomed Pharmacother; 2018 Oct; 106():125-133. PubMed ID: 29957462
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells.
Kim KH; Lee JM; Zhou Y; Harpavat S; Moore DD
Mol Endocrinol; 2016 Aug; 30(8):905-16. PubMed ID: 27355192
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
32. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
33. Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL.
Xu F; Zhou D; Meng X; Wang X; Liu C; Huang C; Li J; Zhang L
Int Immunopharmacol; 2016 Mar; 32():76-86. PubMed ID: 26802603
[TBL] [Abstract][Full Text] [Related]
34. PU.1-deficient mice are resistant to thioacetamide-induced hepatic fibrosis: PU.1 finely regulates Sirt1 expression via transcriptional promotion of
Liu Q; Zhang Y; Yang S; Wu Y; Wang J; Yu W; Liu Y
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162670
[TBL] [Abstract][Full Text] [Related]
35. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
36. Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways.
Cao F; Zhang Y; Li W; Shimizu K; Xie H; Zhang C
Int Immunopharmacol; 2018 Feb; 55():183-192. PubMed ID: 29268190
[TBL] [Abstract][Full Text] [Related]
37. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.
Tian XF; Ji FJ; Zang HL; Cao H
PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128
[TBL] [Abstract][Full Text] [Related]
38. Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis.
Du XS; Li HD; Yang XJ; Li JJ; Xu JJ; Chen Y; Xu QQ; Yang L; He CS; Huang C; Meng XM; Li J
Int Immunopharmacol; 2019 Oct; 75():105671. PubMed ID: 31377590
[TBL] [Abstract][Full Text] [Related]
39. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.
Li X; Yao QY; Liu HC; Jin QW; Xu BL; Zhang SC; Tu CT
J Cell Mol Med; 2017 Oct; 21(10):2370-2385. PubMed ID: 28378526
[TBL] [Abstract][Full Text] [Related]
40. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]